Molecular targeted therapies, omics, and AI based theranostics approaches for the treatment of prostate cancer.

Cancer is a disease that begins with genetic and epigenetic alterations occurring in specific cells, some of which can spread and migrate to other tissues. Prostate cancer ranks as one of the most prevalent malignancies among men globally, particular…

Preview only. Read the full abstract at the source